Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report
Yıl: 2020 Cilt: 66 Sayı: 3 Sayfa Aralığı: 364 - 367 Metin Dili: İngilizce DOI: 10.5606/tftrd.2020.4286 İndeks Tarihi: 30-06-2021
Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report
Öz: Both human immunodeficiency virus (HIV) infection and antiretroviral therapy are related to an increased risk of fracture. As a result of the developments in HIV treatment in recent years, life expectancy in HIV-infected patients has increased. Therefore, HIV-related musculoskeletal problems such as osteoporosis and avascular necrosis are more common currently. There are complex mechanisms in HIV-related osteoporosis. The loss of bone mineral density is particularly distinctive in the first months of the therapy. In this report, we present a 54-year-old woman admitted to our clinic with right thigh pain for three months and diagnosed with a femoral neck stress fracture.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Borderi M, Gibellini D, Vescini F, De Crignis E, Cimatti L, Biagetti C, et al. Metabolic bone disease in HIV infection. AIDS 2009;23:1297-310.
- 2. Carson JS, Bostrom MPG. HIV-associated osteopenia and osteoporosis. Curr Opin Orthop 2006;17:456-61.
- 3. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010;51:937-46.
- 4. Miller KD, Masur H, Jones EC, Joe GO, Rick ME, Kelly GG, et al. High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002;137:17-25.
- 5. Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis 2003;37:944-50.
- 6. Bedimo R, Maalouf NM, Zhang S, Drechsler H, Tebas P. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS 2012;26:825-31.
- 7. Brown TT, Mallon PW. Editorial: Working towards an understanding of bone disease in HIV. Curr Opin HIV AIDS 2016;11:251-2.
- 8. de Menezes EG, Machado AA, Barbosa F Jr, de Paula FJ, Navarro AM. Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection. J Bone Miner Metab 2017;35:234-42.
- 9. Cotter EJ, Malizia AP, Chew N, Powderly WG, Doran PP. HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses 2007;23:1521-30.
- 10. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006;20:2165-74.
- 11. Jones S, Restrepo D, Kasowitz A, Korenstein D, Wallenstein S, Schneider A, et al. Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int 2008;19:913-8.
- 12. Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS 2009;23:1519-29.
- 13. Martin A, Bloch M, Amin J, Baker D, Cooper DA, Emery S, et al. Simplification of antiretroviral therapy with tenofoviremtricitabine or abacavir-Lamivudine: a randomized, 96-week trial. Clin Infect Dis 2009;49:1591-601.
- 14. Moyle GJ, Sabin CA, Cartledge J, Johnson M, Wilkins E, Churchill D, et al. A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS 2006;20:2043-50.
- 15. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 2004;292:191-201.
- 16. McComsey GA, Huang JS, Woolley IJ, Young B, Sax PE, Gerber M, et al. Fragility fractures in HIV-infected patients: need for better understanding of diagnosis and management. J Int Assoc Physicians AIDS Care (Chic) 2004;3:86-91.
- 17. Perrot S, Aslangul E, Szwebel T, Caillat-Vigneron N, Le Jeunne C. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. J Clin Rheumatol 2009;15:72-4.
- 18. Torres Isidro MV, García Benayas T, del Val Gómez Martínez M, González Gallardo F, Gambí Pisonero N, Castilla Miguel S, et al. Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir. Rev Esp Med Nucl 2006;25:103-6.
- 19. Wanner DP, Tyndall A, Walker UA. Tenofovir-induced osteomalacia. Clin Exp Rheumatol 2009;27:1001-3.
- 20. Ilha TASH, Comim FV, Copes RM, Compston JE, Premaor MO. HIV and Vertebral Fractures: a Systematic Review and Metanalysis. Sci Rep 2018;8:7838.
- 21. Llop M, Sifuentes WA, Bañón S, Macia-Villa C, Perez-Elías MJ, Rosillo M, et al. Increased prevalence of asymptomatic vertebral fractures in HIV-infected patients over 50 years of age. Arch Osteoporos 2018;13:56.
- 22. Natsag J, Kendall MA, Sellmeyer DE, McComsey GA, Brown TT. Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density. HIV Med 2016;17:196-205.
- 23. Negredo E, Warriner AH. Pharmacologic approaches to the prevention and management of low bone mineral density in HIV-infected patients. Curr Opin HIV AIDS 2016;11:351-7.
- 24. Black DM, Reid IR, Boonen S, Bucci-Rechtweg C, Cauley JA, Cosman F, et al. The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res 2012;27:243-54.
- 25. Schilcher J, Koeppen V, Ranstam J, Skripitz R, Michaëlsson K, Aspenberg P. Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone 2013;52:389-92.
- 26. Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2014;29:1-23.
- 27. Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, et al. Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis. J Clin Endocrinol Metab 2019;104:1623-30.
| APA | Terlemez R, Sonmez M, Hamidi A, Yilmaz F (2020). Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. , 364 - 367. 10.5606/tftrd.2020.4286 |
| Chicago | Terlemez Rana,Sonmez Mesut,Hamidi Aziz Ahmad,Yilmaz Figen Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. (2020): 364 - 367. 10.5606/tftrd.2020.4286 |
| MLA | Terlemez Rana,Sonmez Mesut,Hamidi Aziz Ahmad,Yilmaz Figen Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. , 2020, ss.364 - 367. 10.5606/tftrd.2020.4286 |
| AMA | Terlemez R,Sonmez M,Hamidi A,Yilmaz F Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. . 2020; 364 - 367. 10.5606/tftrd.2020.4286 |
| Vancouver | Terlemez R,Sonmez M,Hamidi A,Yilmaz F Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. . 2020; 364 - 367. 10.5606/tftrd.2020.4286 |
| IEEE | Terlemez R,Sonmez M,Hamidi A,Yilmaz F "Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report." , ss.364 - 367, 2020. 10.5606/tftrd.2020.4286 |
| ISNAD | Terlemez, Rana vd. "Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report". (2020), 364-367. https://doi.org/10.5606/tftrd.2020.4286 |
| APA | Terlemez R, Sonmez M, Hamidi A, Yilmaz F (2020). Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. Turkish Journal of Physical Medicine and Rehabilitation, 66(3), 364 - 367. 10.5606/tftrd.2020.4286 |
| Chicago | Terlemez Rana,Sonmez Mesut,Hamidi Aziz Ahmad,Yilmaz Figen Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. Turkish Journal of Physical Medicine and Rehabilitation 66, no.3 (2020): 364 - 367. 10.5606/tftrd.2020.4286 |
| MLA | Terlemez Rana,Sonmez Mesut,Hamidi Aziz Ahmad,Yilmaz Figen Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. Turkish Journal of Physical Medicine and Rehabilitation, vol.66, no.3, 2020, ss.364 - 367. 10.5606/tftrd.2020.4286 |
| AMA | Terlemez R,Sonmez M,Hamidi A,Yilmaz F Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. Turkish Journal of Physical Medicine and Rehabilitation. 2020; 66(3): 364 - 367. 10.5606/tftrd.2020.4286 |
| Vancouver | Terlemez R,Sonmez M,Hamidi A,Yilmaz F Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report. Turkish Journal of Physical Medicine and Rehabilitation. 2020; 66(3): 364 - 367. 10.5606/tftrd.2020.4286 |
| IEEE | Terlemez R,Sonmez M,Hamidi A,Yilmaz F "Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report." Turkish Journal of Physical Medicine and Rehabilitation, 66, ss.364 - 367, 2020. 10.5606/tftrd.2020.4286 |
| ISNAD | Terlemez, Rana vd. "Atypical femoral neck stress fracture in a human immunodeficiencyvirus-infected patient despite anti-osteoporotic treatment: A case report". Turkish Journal of Physical Medicine and Rehabilitation 66/3 (2020), 364-367. https://doi.org/10.5606/tftrd.2020.4286 |
